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Effects
of Ractopamine
(Optaflexx) Fed in Combination
with Melengestrol Acetate on
Feedlot Heifer Performance1
W. A. Griffin,* G. E. Erickson,*2 PAS, B. D. Dicke,† PAS, T. J. Klopfenstein,* R. J. Cooper,†
D. J. Jordon,† R. S. Swingle,‡ W. M. Moseley,§ G. E. Sides,§ and D. J. Weigel§
*Department of Animal Science, University of Nebraska, Lincoln 68583-0908; †Cattlemen’s
Nutrition Services, Lincoln, NE 68516; ‡Cactus Feeders, Amarillo, TX 79116; and §Pfizer Inc.,
Kalamazoo, MI 49001

ABSTRACT
Two commercial feedlot experiments
were conducted to determine the effects
of feeding melengestrol acetate (MGA)
or MGA plus ractopamine (MGA+OPT)
on the performance and carcass characteristics of finishing heifers. In Nebraska
(Exp. 1), 1,807 heifers (337.3 ± 20.0
kg) and in Texas (Exp. 2), 1,964 heifers (331.5 ± 6.1 kg) were fed 0.4 mg of
MGA daily. For heifers fed MGA+OPT,
200 mg of ractopamine was fed daily the
last 29 (Exp. 2) or 36 d (Exp. 1). Live
and carcass-adjusted performance data
were collected. On a carcass-adjusted
basis, G:F for the entire feeding period
was improved (P < 0.01) by 1.7 and
3.7% in Exp. 1 and 2, respectively, for
heifers fed MGA+OPT compared with
MGA. For the last 29 to 36 d, G:F was
increased (P < 0.02) by 8.1% (Exp. 1) or
27.2% (Exp. 2) on a carcass-adjusted basis for heifers fed MGA+OPT compared
with MGA. Fat thickness, USDA YG,
marbling score, LM area, and percent1
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age USDA Choice were not different (P
> 0.47) between treatments in Exp. 1.
Carcasses from heifers fed MGA+OPT
had decreased marbling scores (P = 0.01)
and greater LM area (P = 0.01) than
carcasses from heifers fed MGA in Exp.
2. In Exp. 1, in which G:F was improved
by 8.1%, no effect on QG was observed.
In Exp. 2, in which G:F was improved
by 27.2%, QG decreased. Based on these
results, feeding MGA+OPT increased
ADG and improved G:F, with variable
effects on carcass characteristics.
Key words: feedlot cattle, heifer,
melengestrol acetate, Optaflexx, ractopamine

INTRODUCTION
Melengestrol acetate (Pfizer Animal Health, New York City, NY) is
an easily administered, orally active
progestogen that has been shown to
increase BW gain and improve feed
efficiency when compared with heifers that did not receive melengestrol
acetate during the finishing period
(Bloss et al., 1966; Lauderdale, 1983;
Kreikemeier and Mader, 2004). Feeding melengestrol acetate inhibits
estrus and ovulation and is a prod-

uct commonly fed daily to finishing
heifers at an inclusion level of 0.25
to 0.50 mg/heifer. Carcass weights
are the ultimate weight measure
for determining the final value of
a beef animal (Owens et al., 1993).
β-Adrenergic agonists have been
shown to cause changes in growth
with increased accretion of skeletal
muscle and decreased accretion of fat
(Mersmann, 1998). Optaflexx (Elanco
Animal Health, Greenfield, IN), the
trade name for ractopamine-HCl, is a
β-1 adrenergic agonist. When Optaflexx was fed to heifers the last 28 to
42 d of the finishing period, heifers
had increased weight gain on both a
carcass-adjusted and BW basis, improved feed efficiency, and no change
in marbling when fed at a rate of
10.0, 20.0, or 30.0 g/ton (Schroeder
et al., 2003b). The increased BW and
carcass weight were 7.2 and 2.9 kg,
respectively, for heifers fed 200 mg/
heifer daily. The BW response to
feeding Optaflexx to heifers is less
than the response in steers (Schroeder
et al., 2003a,b; Laudert et al., 2004).
These previous studies were completed before MGA was cleared to be fed
with Optaflexx; therefore, diets did
not include melengestrol acetate, nor
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did heifers receive implants containing
trenbelone acetate. The objective of
these experiments was to determine
the effect of feeding Optaflexx in
combination with melengestrol acetate
on finishing heifer performance and
carcass merit.

MATERIALS AND METHODS
Experiment 1
The experiment was conducted
at a commercial feedlot in central
Nebraska between August 2004 and
March 2005 using 1,807 British ×
Continental heifers (337.3 kg ± 20.0)
fed in 20 pens (10 pens/treatment).
After arrival, heifers were individually
weighed, processed, and blocked by
date received and site of procurement.
Therefore, within each replication,
cattle were received on the same day
and from the same point of origin in
a balanced fashion. During initial processing, heifers were vaccinated for viral diseases (BoviShield Gold 4, Pfizer
Animal Health), treated for internal
and external parasites (Dectomax
Injectable, Pfizer Animal Health),
and implanted with Ralgro (SheringPlough Animal Health, Union, NJ).
Heifers were determined to be bred,
open, or freemartins by rectal palpation. Freemartins and heifers more
than 100 d pregnant were removed
from the trial. Heifers less than 100
d pregnant were given a single 5-mL
injection of Lutalyse (Pfizer Animal
Health). Heifers diagnosed as open
were not injected with Lutalyse.
Therefore, if heifers were very early in
pregnancy and unable to be identified
as pregnant via rectal palpation, those
heifers remained on trial. Heifers
from separate locations were assigned
randomly using processing order and
by sorting every other heifer through
the chute to 1 of 2 treatments. Heifers
were then assigned randomly to their
home pen (10 replications/treatment)
with an average of 90 heifers/pen
(range 60 to 145 heifers/pen). Treatments were 1) heifers fed melengestrol
acetate for the entire finishing period
(MGA), and 2) heifers fed melengestrol acetate for the entire finishing
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period and Optaflexx the last 31 to
38 d (MGA+OPT). Within each
replication, heifers were monitored the
same number of days during Optaflexx feeding in a balanced manner.
Once initially processed, heifers were
adapted to high-grain finishing diets;
however, melengestrol acetate was
not included during grain adaptation.
The finishing diet was formulated to
provide 0.4 mg/heifer of melengestrol
acetate, 330 mg/heifer of Rumensin
(Elanco Animal Health), and 90
mg/heifer of Tylan (Elanco Animal
Health) daily. During the last 31 to 38
d of finishing (average of 35.5 across
all 10 replications), Optaflexx was
included in the diet to achieve a daily
intake of 200 mg/heifer for heifers fed
the MGA+OPT treatment.
Heifers were reimplanted with
Synovex Plus (Fort Dodge Animal
Health, Overland Park, KS) an average of 80 d preslaughter (range 73 to
87 d), with animals implanted on the
same day within arrival block. The
final diet contained 38% dry-rolled
corn, 29.5% steam-flaked corn, 18%
wet distillers grains plus solubles, 6%
alfalfa hay, 2% sorghum hay, 1.5%
fat, and 5% supplement in the control
diet (DM basis). The MGA+OPT
supplement was delivered in a pelleted
form fed at 4% of the dietary DM to
replace dry-rolled corn. The Optaflexx
supplement consisted of finely ground
corn and wheat middlings. Diet
samples were taken once a month and
analyzed at a commercial laboratory.
The finishing diet contained 14.9%
CP, 0.72% Ca, 0.37% P, and 6.9%
fat (DM basis). Heifers were fed an
average of 133 d (range of 126 to 143
d balanced within each replication).
Feed intake was calculated by using
the amount of feed delivered to the
bunk of each individual pen of cattle
and corrected for DM of ingredients.
Performance was summarized on
both a live BW basis as well as a
carcass-adjusted basis. For live BW
performance, pen BW were taken for
each pen at initial processing, reimplantation, the beginning of Optaflexx
feeding, and before shipment on the
day of slaughter. Pen weights were
shrunk 4%. Initial pen BW were not

shrunk because animals were processed immediately upon arrival or
after an overnight receiving period.
Pen weights were used for performance calculations on a live BW
basis. Carcass weights were adjusted
to a common dressing percentage of
63.5% to calculate a carcass-adjusted
final BW. The constant dressing
percentage of 63.5% was used in both
experiments to reduce the variation
in BW measures that can occur from
factors such as gut fill (MacDonald et
al., 2007). Carcass-adjusted final BW
was used to determine ADG and G:F
on a carcass-adjusted basis.
Both pens within a block (replication) were harvested under similar
conditions on the same day at the
same plant. Hot carcass weights
(HCW) and liver abscesses were
recorded on the day of slaughter.
Carcass fat thickness, USDA called
marbling score, KPH, LM area, and
USDA YG were recorded after a
24- to 36-h chill. Yield grade was
calculated as 2.5 + (6.35 × fat thickness, cm) + (0.0017 × HCW, kg) +
(0.2 × KPH, %) − (2.06 × LM area,
cm2), from Boggs and Merkel (1993).
Empty body fat was calculated as
17.76207 + (4.68142 × rib fat thickness, cm) + (0.01945 × HCW, kg) +
(0.81855× marbling/100) − (0.06754
× LM area, cm2), from (Guiroy et al.,
2002).

Experiment 2
This experiment was conducted at
a commercial feedlot located in the
Texas Panhandle between October
2004 and February 2005 using 1,964
(331.5 kg ± 6.1) British × Continental heifers fed in 20 pens (10 pens/
treatment). After arrival, heifers were
individually weighed, processed, and
blocked by date received and site of
procurement. During initial processing, heifers were vaccinated for viral
diseases (BoviShield Gold 4 and Fortress 7, Pfizer Animal Health), treated for internal and external parasites
(Dectomax Injectable, Pfizer Animal
Health), and given a single Revalor H
implant (Intervet Inc., Millsboro, DE)
at arrival. Heifers were determined to
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be bred, open, or freemartins by rectal palpation. Freemartins and heifers
more than 100 d bred were removed
from the trial. Heifers determined to
be less than 100 d bred were given
a single 5-mL injection of Lutalyse.
Heifers diagnosed as open were not injected with Lutalyse, which, similar to
Exp. 1, allowed some heifers in early
pregnancy to complete the trial. Heifers were allocated to 1 of 2 treatments
by gate-sorting groups of 2. Heifers
were then assigned to 1 of 20 home
pens (10 replications/treatment) with
an average of 98 heifers/pen (range
84 to 107). Treatments were identical to Exp. 1, with heifers fed either
melengestrol acetate (MGA) for the
entire finishing period or fed MGA

for the entire finishing period and
Optaflexx the last 29 d (range 28 to
29 d; MGA+OPT). The finishing
diet was formulated to provide 0.4
mg/heifer of MGA, 330 mg/heifer of
Rumensin, and 90 mg/heifer Tylan
daily. The Optaflexx was included
in the diet to provide 200 mg/heifer
daily for heifers fed the MGA+OPT
treatment. Heifers were fed a finishing
diet containing 74.1% steam-flaked
corn, 7.5% dried distillers grains,
6.6% corn silage, 4.8% alfalfa hay,
3.0% tallow, and 4.0% supplement
(DM basis). Feed additives (MGA,
Rumensin, and Tylan) were added to
the diet with a micro-weigh machine
in the feedmill (Micro Beef Technologies, Amarillo, TX). The Optaflexx

Table 1. Live performance and carcass-adjusted performance for
finishing heifers fed melengestrol acetate or melegestrol acetate plus
Optaflexx in Exp. 1
Item
Live performance
Initial BW, kg
Reimplant BW, kg
Start of Optaflexx BW, kg
Final BW, kg
Overall3
   DMI, kg/d
   ADG, kg/d
   G:F
Last 35.5 d4
   DMI, kg/d
   Total BW gain, kg
   ADG, kg/d
   G:F
Carcass-adjusted performance5
Final BW, kg
Overall
   ADG, kg/d
   G:F
Last 35.5 d
   Total BW gain, kg
   ADG, kg/d
   G:F

MGA1
337.1
448.6
523.2
570.4

MGA+OPT2
336.2
447.2
525.5
577.4

SEM
6.3
8.6
7.5
7.8

P-value
0.77
0.88
0.73
0.53

10.61
1.75
0.165

10.78
1.81
0.168

0.21
0.05
0.003

<0.01
0.41
0.03

10.37
47.2
1.35
0.128

10.67
51.9
1.48
0.137

0.13
1.96
0.06
0.004

0.01
0.09
0.09
0.07

573.2

580.5

7.5

<0.01

1.88
0.177

1.94
0.180

0.05
0.001

<0.01
<0.01

50.1
1.41
0.136

55.1
1.56
0.146

2.5
0.07
0.007

0.02
0.01
0.02

1

MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York
City, NY) was administered alone for the entire feeding period.

2

MGA+OPT = treatment in which melengestrol acetate was administered for the
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was
included in the ration for the last 35.5 d of the finishing period.

3

Heifer performance over the entire finishing period.

4

Heifer performance during inclusion of Optaflexx in diet for the last 35.5 d before
slaughter.

5

Carcass-adjusted performance is hot carcass weight/0.635.

35

was hand-weighed and added to the
treatment diet using a water flush
and was mixed on the feed truck at
each feeding. Diets were tested once a
month and analyzed at a commercial
laboratory. The finishing diet contained 13.6% CP, 0.56% Ca, 0.32%
P, and 7.48% fat (DM basis). Heifers
were fed an average of 138 d (range
of 135 to 140 d, balanced within each
replication).
Pen BW were taken for each pen
at initial processing, at the beginning of Optaflexx feeding, and before
shipment on the day of slaughter.
Pen BW were shrunk 4% except for
initial pen BW because animals were
processed immediately upon arrival.
Pen BW were used for performance
calculations on a BW basis. Carcass
weights were adjusted to a common dressing percentage of 63.5%
to calculate a carcass-adjusted final
BW. Carcass-adjusted final BW was
used to determine ADG and G:F on a
carcass-adjusted basis.
All pens in this experiment were
harvested on the same day at the
same abattoir. Hot carcass weights
and liver abscesses were recorded on
the day of harvest. Carcass fat thickness, USDA called marbling score,
KPH, LM area, and USDA YG were
recorded after a 24-h chill. Yield
grade and empty body fat were calculated as defined for Exp. 1.

Statistical Analysis
Experiments 1 and 2 were analyzed
as a randomized block design. Animal
performance and carcass data were
analyzed using the MIXED procedure (SAS Inst. Inc., Cary, NC), with
treatment as a fixed effect and block
as a random effect. In this study,
pen was used as the experimental
unit. The USDA marbling score and
calculated YG were analyzed using a
chi-square analysis. Data are presented with dead animals and railers
removed from the analysis.

Griffin et al.
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Table 2. Carcass characteristics for finishing heifers fed melengestrol
acetate or melengestrol acetate plus Optaflexx in Exp. 1
Item

MGA1

MGA+OPT2

SEM

P-value

Hot carcass weight, kg
Fat thickness, cm
YG3
YG 1, %
YG 2, %
YG 3, %
YG 4, %
YG 5, %
Marbling4
Prime, %
Choice +, %
Choice0, %
Choice−, %
Select, %
Standard, %
LM area, cm2
KPH, %
Dressing percentage, %
Empty body fat,5 %

364.7
1.43
2.74
19.1
44.7
29.9
5.5
0.7
553.6
1.2
4.9
20.0
45.8
27.1
0.9
92.95
1.96
63.82
29.75

368.0
1.42
2.76
17.1
45.7
31.1
5.5
0.6
551.7
1.2
6.5
17.4
46.4
27.5
1.0
92.82
1.95
63.85
29.74

1.7
0.04
0.10
—
—
—
—
—
6.1
—
—
—
—
—
—
1.39
0.01
0.22
0.25

0.02
0.62
0.72
—
—
—
—
—
0.72
—
—
—
—
—
—
0.88
0.24
0.87
0.96

1

MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York
City, NY) was administered alone for the entire feeding period.

2

MGA+OPT = treatment in which melengestrol acetate was administered for the
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was
included in the ration for the last 35.5 d of the finishing period.

3

YG = 2.5 + (6.35 × fat thickness, cm) + (0.0017 × hot carcass weight, kg) + (0.2 ×
KPH, %) − (2.06 × LM area); from Boggs and Merkel (1993).

4

Marbling = 400 = Slight0, 500 = Small0, and so on.

5

Empty body fat = 17.76207 + (4.68142 × rib fat thickness, cm) + (0.01945 × hot
carcass weight, kg) + (0.81855 × marbling/100) − (0.06754 × LM area, cm2); from
Guiroy et al. (2002).

RESULTS AND DISCUSSION
Experiment 1
Fifteen animals (8 MGA+OPT and
7 MGA) were removed from the study
before slaughter. Four and 3 heifers
were removed from the MGA+OPT
and MGA treatments, respectively, after inclusion of Optaflexx. Data were
not collected from 72 rail-outs in the
plant (46 MGA and 26 MGA+OPT
heifers). Of the 1,720 heifers harvested, 852 were fed MGA and 868
were fed MGA+OPT. Fetuses were
observed at slaughter in 82 heifers: 39
in the MGA treatment and 43 in the
MGA+OPT treatment. These pregnant heifers were included in the final
analysis because we observed approximately the same number of heifers
in each treatment, and there was no

difference in performance between
treatments with or without these heifers included.
The diet containing Optaflexx was
formulated to achieve an intake of 200
mg/d per heifer; however, based on
DMI changes across block (range 10.1
to 11.8 kg/d), actual Optaflexx intake
averaged 205.0 mg/d per heifer (range
185.1 to 222.4 mg/d per heifer). Optaflexx is approved to be fed at a rate
of 70 to 430 mg/d per heifer. Animals
consumed an average of 0.371 mg/kg
Optaflexx (range 0.346 to 0.383 mg/
kg) when calculated on a kilogram of
BW basis.
Live and carcass-adjusted performance results are presented in Table
1 for Exp. 1. Final live BW was not
different (P = 0.53), but final live
BW was numerically increased by 7.0

kg or 1.2% in heifers fed MGA+OPT.
Dry matter intake was increased by
0.17 kg/d (P < 0.01) for heifers fed
MGA+OPT compared with heifers fed MGA alone over the entire
feeding period. Feed efficiency was
improved 1.8% (P = 0.03) for heifers
fed MGA+OPT compared with heifers fed MGA, even though ADG was
not affected (P = 0.41) when comparing treatments over the entire 133-d
finishing period on a live BW basis.
When comparing treatments during the last 35.5 d (the time heifers
were fed Optaflexx), heifers receiving
MGA+OPT were numerically heavier
(525.5 vs. 523.2 kg) at the beginning of the period. Given this 2.3-kg
advantage in initial BW for heifers fed
MGA+OPT, the BW gain increase
for heifers assigned to MGA+OPT
was 4.7 kg, an improvement in BW
gain of 10.2% (P = 0.09) compared
with heifers fed MGA. Dry matter
intake was increased (P = 0.01) by
0.30 kg/heifer. Feeding MGA+OPT
increased ADG (live basis) by 0.13
kg/d (P = 0.09), which led to a 7.0%
improvement (P = 0.07) in feed efficiency compared with heifers receiving MGA.
On a carcass-adjusted basis
(HCW/0.635), final BW was increased (P = 0.01) by 7.3 kg or 1.3%
for heifers receiving MGA+OPT compared with heifers fed MGA. When
ADG was calculated from carcass
weight, heifer ADG was increased (P
< 0.01) by 0.06 kg/heifer, with an improvement (P < 0.01) in feed efficiency of 1.7% for heifers over the entire
feeding period. Despite the relatively
small improvement when expressed
over the entire feeding period, ADG
and G:F of heifers fed MGA+OPT
compared with heifers fed MGA on
a carcass-adjusted basis were significantly different. When looking at
only the last 35.5 d of performance,
MGA+OPT heifers gained 0.15 kg/d
more (P = 0.01), and G:F improved
by 8.1% (P = 0.02) compared with
heifers receiving MGA.
Carcasses of heifers in the
MGA+OPT treatment groups
(Table 2) did not differ in USDA YG,
marbling score, percentage of USDA
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choice and select based on chi-square
analysis, fat thickness, LM area,
KPH, empty body fat, cutability, and
dressing percentage when compared
with heifers fed MGA. However,
heifers fed MGA+OPT had 3.3 kg
heavier (0.9%) HCW (P < 0.01).

Experiment 2
Forty-nine heifers (22 MGA+OPT
and 27 MGA) were removed from
the study before slaughter. One and
2 heifers were removed from the
MGA and the MGA+OPT treatment, respectively, after inclusion
of Optaflexx. Of the 1,915 heifers
harvested, 957 were fed MGA and 958
were fed MGA+OPT. Fetuses were

observed in 56 heifers at slaughter:
22 in the MGA treatment and 34 in
the MGA+OPT group. These pregnant heifers were included in the final
analysis for the same reasons as in
Exp. 1.
In this study, the MGA+OPT diet
was formulated to achieve 200 mg/
heifer daily. Based on the method
(micro-weigh machine) in which Optaflexx was delivered to the bunk, DMI
differences (range 8.3 to 9.4 kg) across
block had no effect on actual Optaflexx intake. Therefore, daily intake
of Optaflexx averaged 200 mg/heifer.
Animals consumed an average of
0.384 mg/kg Optaflexx (range 0.366
to 0.396 mg/kg) when calculated on a
per kilogram of BW basis.

Table 3. Live performance and carcass-adjusted performance for
finishing heifers fed melengestrol acetate or melegestrol acetate plus
Optaflexx in Exp. 2
Item
Live performance
Initial BW, kg
Start of Optaflexx BW, kg
Final BW, kg
Overall3
   DMI, kg/d
   ADG, kg/d
   G:F
Last 29 d4
   DMI, kg/d
   Total BW gain, kg
   ADG, kg/d
   G:F
Carcass-adjusted performance5
Final BW, kg
Overall
   ADG, kg/d
   G:F
Last 29 d
   Total BW gain, kg
   ADG, kg/d
   G:F

MGA1
331.9
505.4
534.9

MGA+OPT2
329.7
501.8
539.0

SEM
2.0
3.6
3.5

P-value
0.09
0.43
0.35

8.98
1.47
0.163

8.97
1.52
0.169

0.12
0.02
0.002

0.95
0.10
<0.01

8.82
29.5
1.02
0.113

8.81
37.2
1.28
0.143

0.10
1.4
0.05
0.005

0.94
<0.01
<0.01
<0.01

534.6

539.7

2.2

0.19

1.47
0.163

1.52
0.169

0.02
0.002

0.04
<0.01

29.2
0.99
0.114

37.9
1.29
0.144

1.5
0.05
0.005

<0.01
<0.01
<0.01

1

MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York
City, NY) was administered alone for the entire feeding period.

2

MGA+OPT = treatment in which melengestrol acetate was administered for the
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was
included in the ration for the last 29 d of the finishing period.

3

Heifer performance over the entire finishing period.

4

Heifer performance during inclusion of Optaflexx in diet for the last 29 d before
slaughter.

5

Carcass-adjusted performance is hot carcass weight/0.635.
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Heifer live and carcass-adjusted
performance results are presented
in Table 3. Final live BW was not
different (P = 0.35) between treatments, although heifers receiving
MGA+OPT were 4.1 kg (0.8%)
heavier than animals receiving MGA.
Total BW gain during Optaflexx feeding was greater (P < 0.01) for heifers
receiving MGA+OPT compared with
heifers receiving MGA. The DMI was
not affected by feeding Optaflexx (P
= 0.95) over the entire feeding period.
Average daily gain was not statistically different (P = 0.10), but showed
a numerical increase of 0.05 kg/d for
heifers fed MGA+OPT compared
with heifers fed MGA. Feed efficiency was improved by 3.7% when
Optaflexx was included in the diet
of heifers receiving MGA (P < 0.01),
even though DMI and ADG were only
slightly affected over the entire 138-d
feeding period.
Over the last 29 d on feed (the time
heifers were receiving Optaflexx),
DMI was not influenced (P = 0.94)
by treatment. Final BW minus BW
at the beginning of Optaflexx feeding
exhibited a 7.7-kg (P < 0.01) improvement in BW gain in MGA+OPT
compared with heifers fed MGA.
Feeding MGA+OPT increased ADG
0.26 kg/d (25.5%) when compared
with heifers receiving MGA (P <
0.01). Increased ADG, without a
change in DMI, caused heifers receiving MGA+OPT to be 26.5% more
efficient (P < 0.01) compared with
heifers receiving MGA.
Carcass-adjusted live performance
(HCW/0.635) over the entire feeding period indicated heifers receiving
MGA+OPT had a 5.1 kg heavier adjusted final BW (P = 0.19). Because
of the difference in heifer BW at the
initiation of Optaflexx, BW gained
over the last 29-d period was 37.9 kg
for MGA+OPT compared with 29.2
kg for heifers receiving MGA, an 8.7kg difference (P < 0.01). Heifers receiving MGA+OPT gained 0.05 kg/d
(3.4%) more (P = 0.04) when compared with heifers receiving MGA.
Feed efficiency was also improved by
3.7% (P < 0.01) for heifers receiving MGA+OPT. During the last 29
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d of the feeding period, heifers fed
MGA+OPT gained 0.30 kg/d more
(P < 0.01), a 30.3% improvement,
and exhibited an improvement in G:F
of 27.2% (P < 0.01) over MGA heifers.
Carcasses of heifers fed MGA+OPT
were 3.2 kg heavier than those from
heifers fed MGA (Table 4). However, because of the difference in
BW at the beginning of Optaflexx
feeding, initial BW at the beginning
of Optaflexx feeding (BW × 0.635
subtracted from the HCW) was used
to determine the amount of carcass
weight gained in the last 29 d of the
feeding period. With this approach,
heifers receiving MGA+OPT gained
24.1 kg of carcass weight compared
with 18.6 kg for heifers receiving
MGA. Assuming that differences
in live BW are real, heifers receiv-

ing Optaflexx actually gained 5.5 kg
more (instead of 3.4 kg) than heifers
receiving MGA. When other carcass
characteristics were compared, no
significant differences were observed
between MGA and MGA+OPT for
fat thickness, KPH fat, dressing percentage, empty body fat, or cutability.
Carcasses of heifers fed MGA+OPT
had reduced marbling scores (P =
0.01) and 2.37 cm2 greater LM area
(P = 0.01) and tended to exhibit
reduced YG (2.48 vs. 2.59; P = 0.11)
compared with carcasses from heifers fed MGA. Carcasses from heifers
receiving MGA+OPT graded 59.9%
Low Choice or better compared with
71.4% for heifers receiving MGA (P
= 0.05).
Previous research by Laudert et al.
(2004) and Schroeder et al. (2003a)
showed steers receiving Optaflexx

Table 4. Carcass characteristics for finishing heifers fed melengestrol
acetate or melengestrol acetate plus Optaflexx in Exp. 2
Item

MGA1

MGA+OPT2

SEM

P-value

Hot carcass weight, kg
Fat thickness, cm
YG3
YG 1, %
YG 2, %
YG 3, %
YG 4, %
YG 5, %
Marbling4
Prime, %
Choice +, %
Choice0, %
Choice−, %
Select, %
Standard, %
LM area, cm2
KPH, %
Dressing percentage, %
Empty body fat,5 %

339.5
1.36
2.59
24.8
43.5
27.0
4.5
0.2
534.0
0.9
0.8
11.7
58.0
28.3
0.3
90.24
1.88
63.47
28.18

342.7
1.35
2.48
28.5
47.6
19.1
4.4
0.4
519.4
1.5
0.5
8.5
49.4
39.5
0.6
92.61
1.86
63.58
27.89

2.2
0.05
0.07
—
—
—
—
—
7.1
—
—
—
—
—
—
0.72
0.01
0.09
0.31

0.19
0.72
0.11
—
—
—
—
—
0.01
—
—
—
—
—
—
0.01
0.36
0.39
0.27

1

MGA = treatment in which melengestrol acetate (Pfizer Animal Health, New York
City, NY) was administered alone for the entire feeding period.

2

MGA+OPT = treatment in which melengestrol acetate was administered for the
entire feeding period and Optaflexx (Elanco Animal Health, Greenfield, IN) was
included in the ration for the last 29 d of the finishing period.

3

YG = 2.5 + (6.35 × fat thickness, cm) + (0.0017 × hot carcass weight, kg) + (0.2 ×
KPH, %) − (2.06 × LM area); from Boggs and Merkel (1993).

4
5

Marbling = 400 = Slight0, 500 = Small0, etc.

Empty body fat = 17.76207 + (4.68142 × rib fat thickness, cm) + (0.01945 × hot
carcass weight, kg) + (0.81855 × marbling/100) − (0.06754 × LM area, cm2); from
Guiroy et al. (2002).

gained, respectively, 6.7 and 7.2 kg
of BW more compared with control steers. Carcass weight was also
increased by 5.6 and 6.4 kg compared
with control steers. Similar responses
were observed by Abney et al. (2007),
in which final BW, ADG, and G:F increased linearly as the Optaflexx dose
increased from 0 to 200 mg of Optaflexx daily. Final BW increased by
9.4 kg and carcass weight increased
by 6.9 kg for steers fed 200 mg of
Optaflexx for either 28, 35, or 42 d
compared with no Optaflexx (Abney
et al., 2007). These authors did not
observe an interaction between length
of feeding and dose. Winterholler et
al. (2007) observed an 11-kg increase
in final BW and an 8-kg increase in
HCW for steers fed 200 mg of Optaflexx daily for 28 d in a commercial
study.
However, with heifers, Schroeder et
al. (2003b) found that those fed Optaflexx were 6.6 kg heavier (live BW
basis) and had 2.9-kg heavier carcasses compared with heifers not fed
Optaflexx. At the time of their heifer
research, Optaflexx was not approved
to be fed with melengestrol acetate.
Therefore, melengestrol acetate was
not included in the diet and heifers
were not implanted with trenbelone
acetate. In the current study, live
BW and carcass gain responses to
Optaflexx with melengestrol acetate
feeding were greater than previously
observed for heifers not fed melengestrol acetate. Responses of the current
study are more comparable with those
observed in steers and in more recent
heifer studies. Walker et al. (2006)
individually fed 72 heifers 0 or 200 mg
Optaflexx with melengestrol acetate
included and observed a 6.9-kg increase in HCW when averaged across
different protein treatments (with no
interaction observed). In their study,
ADG and G:F were increased by approximately 25% and were significant
when using carcass-adjusted performance.
Quinn et al. (2008) fed approximately 300 heifers either 0 or 200
mg of Optaflexx and observed an
improvement of only 9.6% in G:F in
their first experiment, with no signifi-
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cant differences in BW or HCW. In
their second experiment, their treatment design was unique in that they
fed Optaflexx at a rate of 200 mg for
28 or 42 d, fed Optaflexx at a rate
of 300 mg for 28 d, or fed a treatment that had increasing amounts of
Optaflexx across 42 d (100 mg, then
200 mg, followed by 300 mg) and
observed that heifers fed Optaflexx
had a 3- to 8-kg increase in HCW
across the different Optaflexx treatments (Quinn et al., 2008). Although
the different treatments containing
Optaflexx were not different from
each other, the heifers fed 200 mg
for 42 d had the numerically greatest
increase in HCW. In our study, heifers
fed Optaflexx for 29 d (Exp. 2) had
a much greater response in ADG and
G:F than heifers fed for an average of
36 d (Exp. 1).
In previous Optaflexx studies
(Schroeder et al., 2003a), DMI was
not affected by treatment, and similar results were observed in Exp. 2.
However, in Exp. 1, DMI was slightly
greater for heifers fed MGA+OPT
compared with heifers fed MGA.
Many experiments have observed no
change in DMI (Abney et al., 2007;
Sissom et al., 2007; Winterholler et
al., 2007).
Previous research (Schroeder et
al., 2003b) showed heifers fed Optaflexx alone demonstrated a 17.5%
improvement (P < 0.03) in ADG
when compared with control heifers
and a 14.0% improvement in G:F (P
< 0.03) during a 28- to 42-d feeding
period. In Exp. 1, ADG was improved
by 10.6% and G:F was improved by
8.1% when Optaflexx was fed. In
Exp. 2, ADG increased 30.3%, with
a 27.2% improvement in G:F for
heifers fed MGA+OPT compared
with heifers fed MGA. The results
from Exp. 1 were not as great as the
improvement shown by Schroeder et
al. (2003b). In Exp. 2, however, heifers fed MGA+OPT performed better
than heifers fed Optaflexx with no
melengestrol acetate (Schroeder et al.,
2003b).
When evaluating the entire feeding
period with shrunk initial BW and
HCW to avoid possible errors in BW

measurement, the response to feeding
MGA+OPT compared with MGA
was 3.2 and 3.4% for Exp. 1 and Exp.
2, respectively. However, G:F was
increased by 1.7 and 3.7% by feeding
MGA+OPT compared with MGA for
Exp. 1 and Exp. 2, respectively. Sissom et al. (2007) evaluated Optaflexx
fed at 200 mg for 28 d in 2 commercial experiments with all feedlot
heifers fed melengestrol acetate. Their
first experiment evaluated 2 implant
regimens factorialized with Optaflexx
(0 or 200 mg), and no interactions between implant regimen and Optaflexx
feeding were observed. Over the 182-d
feeding period, ADG was increased
2.2% and G:F was increased by 3.9%
(Sissom et al., 2007). In their second
experiment, heifers were fed for a total of 129, 150, or 170 d and no interaction between Optaflexx treatment
and days on feed were observed. The
only significant response was observed
for G:F, which increased 2.4% because
of Optaflexx (Sissom et al., 2007).
Schroeder et al. (2003b) found that
feeding Optaflexx had no effect on
fat thickness, KPH, LM area, YG, or
marbling. No carcass quality changes
were observed between heifers fed
MGA or MGA+OPT in Exp. 1.
However, there was an increase in
LM area and a significant decrease
in marbling score in Exp. 2. When
comparing USDA QG, Exp. 1 showed
no difference between treatments for
percent Choice carcasses. In Exp. 2,
there was a difference in carcass QG,
with less USDA Choice carcasses for
heifers fed MGA+OPT vs. MGA
(59.9 vs. 71.4%, respectively).
Heifers were implanted differently
between Exp. 1 and Exp. 2. Heifers
in Exp. 1 received a mild estrogen
implant upon arrival and were reimplanted with a strong combination
implant. Heifers in Exp. 2 were implanted once at arrival with a moderate combination implant. Implants
have been shown to decrease the QG
of cattle (Crouse et al., 1987; Simms
et al., 1988) when comparisons are
made with similar days on feed and
not at the same empty body fat or
composition. When implant programs
were compared at equal empty body
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fat, carcass quality appeared to be
unaffected (Guiroy et al., 2002).
There was no difference between
marbling scores when comparing
implant programs that used a mild
combination or a strong combination
implant program (Morgan, 1997). In
Exp. 1, with an aggressive implant
program, there was no difference in
carcass quality caused by Optaflexx
feeding; however, in Exp. 2, with a
less aggressive implant in heifers fed
MGA+OPT, carcass quality was
decreased compared with feeding
MGA. These data suggest that an
aggressive implant program can be
used in heifers receiving MGA+OPT
without affecting carcass quality. This
conclusion is further supported by
Sissom et al. (2007), who did not observe an interaction between implant
treatments and Optaflexx feeding.
Clearly, previous research with steers
representing different genotypes and
implant programs suggests that the
influence of Optaflexx on carcass
quality characteristics is consistent in
terms of carcass quality (Schroeder et
al., 2003a; Gruber et al., 2007).
In Exp. 2, heifers receiving
MGA+OPT had an empty body fat
percentage that was 0.29 percentage
units less than heifers receiving MGA
(P = 0.27). Although not significant,
this difference in empty body fat may
suggest that heifers were at different
body compositions between these 2
treatments before Optaflexx feeding,
or that body composition was influenced by Optaflexx feeding. Because
no effect of feeding Optaflexx was
observed on body composition in
Exp. 1, and in previous heifer studies (Schroeder et al., 2003b), body
composition may have been different
between heifers on each treatment
before initiation of Optaflexx feeding.
It is unclear what other factors may
have led to different carcass quality responses between treatments in
Exp. 1 and 2. Previous research with
feeding Optaflexx to heifers suggests
no effect on marbling (Walker et al.,
2006; Sissom et al., 2007; Quinn et
al., 2008); however, these studies have
observed variable impacts of feeding
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Optaflexx to heifers in terms of LM
area and fat depth.
Previous research suggests that
providing Optaflexx to heifers at inclusion amounts greater than 200 mg can
lead to decreases in marbling score
(Schroeder et al., 2003b), whereas
ADG and G:F are improved. However,
in previous studies, Optaflexx fed at
rates of 200 mg or less per day did not
negatively affect carcass quality. Heifers consumed 205.0 and 200.0 mg/heifer daily in Exp.1 and 2, respectively,
suggesting that carcass quality should
not be negatively affected. Optaflexx
intakes, expressed as milligrams of
intake per kilogram of BW, were 0.371
and 0.384, respectively, for Exp. 1 and
2. Although this difference is small between Exp. 1 and 2, Optaflexx intake
(on a mg/kg BW basis) may partially
explain the difference in ADG and G:F
responses between experiments.
Based on results from these 2 experiments and previous research with
heifers, the response to MGA+OPT
consistently improved ADG and G:F.
The most difficult response to quantify
consistently across these experiments
appeared to be the absolute BW
response to feeding Optaflexx to heifers. This was likely due to difficulty in
obtaining accurate BW measurements,
especially late in the feeding period.
However, based on these 2 experiments and recent research with heifers
fed Optaflexx, the observed increase
in HCW attributable to Optaflexx
suggests the BW response was greater
for Optaflexx when fed in combination
with melengestrol acetate than in early
studies in which melengestrol acetate
was not fed with Optaflexx. Interestingly, when the BW response was less
within these 2 experiments, no quality
differences were observed (i.e., in Exp.
1). When the BW response was large
in Exp. 2, then marbling score was
slightly reduced; therefore, the effects
on degree of marbling may be influenced by the magnitude of the BW
response.

last 29 to 38 d of the finishing period
in combination with melengestrol
acetate to feedlot heifers will increase
final BW, improve ADG, and improve
feed efficiency compared with feeding
melengestrol acetate alone. Feeding Optaflexx in combination with
melengestrol acetate had variable
impacts on carcass quality. Optaflexx
appears to have no effect on fat thickness, KPH, or empty body fat compared with heifers fed melengestrol
acetate alone.

IMPLICATIONS

Kreikemeier, W. M., and T. L. Mader. 2004.
Effects of growth-promoting agents and season
on yearling feedlot heifer performance. J. Anim.
Sci. 82:2481.

These data suggest that feeding
Optaflexx at 200 mg/heifer during the
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